NCT04897360 is a NA clinical trial of Increased breathing in Hypocapnia, sponsored by Mayo Clinic.

Who is sponsoring NCT04897360?

NCT04897360 is sponsored by Mayo Clinic.

What drugs are being tested in NCT04897360?

Interventions in NCT04897360: Increased breathing, sharpened Romberg test (SRT).

What condition does NCT04897360 study?

NCT04897360 studies Hypocapnia, Balance; Distorted.

Is NCT04897360 still recruiting?

NCT04897360 is currently completed. Last updated 17 January 2023.

Last reviewed 2023-01-17 · How we verify

NCT04897360

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Study to Evaluate the Effects of Sharpened Romberg Testing (SRT) in Healthy Subjects

Completed NA Last updated 17 January 2023

What this trial tests

NA trial testing Increased breathing in Hypocapnia in 20 participants. Completed in 1 January 2023.

Timeline

17 May 2021

Primary endpoint
1 January 2023

1 January 2023

Quick facts

Lead sponsor	Mayo Clinic
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	sequential
Masking	none
Primary purpose	health services research
Enrollment	20
Start date	17 May 2021
Primary completion	1 January 2023
Estimated completion	1 January 2023
Sites	1 location across United States

Drugs / interventions tested

Increased breathing
sharpened Romberg test (SRT)

Conditions studied

Hypocapnia — all drugs for Hypocapnia →
Balance; Distorted — all drugs for Balance; Distorted →

Sponsor

Mayo Clinic

Who can join

Adults 21 to 55, any sex, with Hypocapnia or Balance; Distorted. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research study is being done to evaluate the effectiveness of using the sharpened Romberg test to screen for impaired postural control in patients with impaired or altered breathing patterns.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Mayo Clinic trials

Trials by the same sponsor.

NCT07126548 — A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men · NA · not yet recruiting
NCT07221656 — Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration · not yet recruiting
NCT06891001 — The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance, · NA · not yet recruiting
NCT07169799 — Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE) · NA · recruiting
NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04897360 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mayo Clinic
Last refreshed: 17 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04897360.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing